KENNEDY CAPITAL MANAGEMENT LLC - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 117 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
KENNEDY CAPITAL MANAGEMENT LLC ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$4,685,796
+362.6%
4,881,037
+3895.9%
0.11%
+336.0%
Q3 2019$1,013,000
-6.4%
122,151
-2.8%
0.02%
-3.8%
Q2 2019$1,082,000
-60.1%
125,618
-50.5%
0.03%
-18.8%
Q1 2019$2,714,000
+219.7%
253,966
+161.7%
0.03%
+52.4%
Q4 2018$849,000
-48.0%
97,035
-0.2%
0.02%
-30.0%
Q3 2018$1,634,000
-75.8%
97,246
-69.8%
0.03%
-76.2%
Q2 2018$6,754,000
+80.9%
322,244
+38.9%
0.13%
+72.6%
Q1 2018$3,733,000
+30.5%
232,027
+53.7%
0.07%
+43.1%
Q4 2017$2,861,000
-60.5%
150,992
-70.7%
0.05%
-61.1%
Q3 2017$7,252,000
+98.2%
515,419
+5.0%
0.13%
+87.1%
Q2 2017$3,659,000
+78.1%
491,075
+55.4%
0.07%
+94.4%
Q1 2017$2,054,000
+51.4%
315,934
+40.4%
0.04%
+33.3%
Q4 2015$1,357,000
-20.5%
225,024
-21.2%
0.03%
-22.9%
Q3 2015$1,707,000
+92.0%
285,531
+119.6%
0.04%
+118.8%
Q2 2015$889,000
-87.2%
130,000
-84.8%
0.02%
-87.6%
Q2 2014$6,941,000
-6.5%
853,791
-9.8%
0.13%
-7.9%
Q1 2014$7,424,000
-10.3%
946,886
+1.3%
0.14%
-8.5%
Q4 2013$8,272,000
+1.3%
934,674
-4.1%
0.15%
-3.2%
Q3 2013$8,167,000
+10.6%
974,608
-1.5%
0.16%
+5.3%
Q2 2013$7,382,000989,5340.15%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders